Search Result

Results for "

Cd40 Inhibitors

" in MCE Product Catalog:

By Targets:	Apoptosis (1) Cytochrome P450 (1) Fluorescent Dye (1) Interleukin Related (1) JAK (1) NF-κB (1) TNF Receptor (5)
By Research Areas:	Cancer (1) Cardiovascular Disease (1) Inflammation/Immunology (6) Metabolic Disease (2)

Inhibitors & Agonists

Fluorescent Dye

Inhibitory Antibodies

Isotope-Labeled Compounds

Cat. No.	Product Name	Target	Research Areas

HY-122663A

BIO8898	TNF Receptor Apoptosis	Metabolic Disease
BIO8898 is a potent *CD40-CD154* inhibitor. BIO8898 inhibits soluble CD40L binding to CD40-Ig with an IC₅₀ value of 25 µM. BIO8898 inhibits CD40L-induced apoptosis.

HY-122663

(Rac)-BIO8898
TNF Receptor Cancer

(Rac)-BIO8898 is a CD40-CD154 co-stimulatory interaction inhibitor. (Rac)-BIO8898 inhibits CD154 binding to CD40-Ig with an IC₅₀ of 25 μM.

(Rac)-BIO8898	TNF Receptor	Cancer
(Rac)-BIO8898 is a CD40-CD154 co-stimulatory interaction inhibitor. (Rac)-BIO8898 inhibits CD154 binding to CD40-Ig with an IC₅₀ of 25 μM.

HY-125025

SMI 6860766	TNF Receptor	Metabolic Disease Inflammation/Immunology
SMI 6860766, a small molecule inhibitor of CD40-TRAF6 interaction, improves glucose tolerance, reduces immune cell accumulation in adipose tissue, and reduces AT inflammation.

HY-D1124

Mordant brown 1	Fluorescent Dye	Others
Mordant brown 1, a naphthalenesulphonic acid derivative, is an azo dye. Mordant brown 1 is also an effective and specific inhibitor of CD40-CD154 costimulatory protein-protein interaction.

HY-120323

DRI-C21045	TNF Receptor	Inflammation/Immunology
DRI-C21045 (compound 10) is a potent and selective inhibitor of the *CD40-CD40L* costimulatory protein-protein interaction (PPI) with an IC₅₀ of 0.17 µM. DRI-C21045 shows concentration-dependent inhibition of the activation of NF-κB and B cell proliferation all induced by CD40L with IC₅₀s of 17.1 µM and 4.5 µM, respectively.

HY-110247

TRAF-STOP inhibitor 6877002	TNF Receptor NF-κB	Inflammation/Immunology Cardiovascular Disease
TRAF-STOP inhibitor 6877002, is a selective inhibitor of *CD40-TRAF6* interaction, compound VII, shows inhibition of NF-κB activation in RAW cells, extracted from patent WO2014033122A1. TRAF-STOP 6877002 prevents the progression of established atherosclerosis in mice, reduces leukocyte recruitment and reduces macrophage activation; reduces macrophage proliferation in atherosclerotic plaques.

HY-131968

BMS-986202	JAK Cytochrome P450	Inflammation/Immunology
BMS-986202 is a potent, selective and orally active Tyk2 inhibitor that binds to Tyk2 JH2 with an IC₅₀ value of 0.19 nM and a K_i of 0.02 nM. BMS-986202 is remarkably selective over other kinases including Jak family members. BMS-986202 is also a weak inhibitor of CYP2C19 with an IC₅₀ value of 14 μM. BMS-986202 can be used for IL-23-driven acanthosis, anti-CD40-induced colitis, and spontaneous lupus research. BMS-986202 is a de novo deuterium.

HY-16668

Tyrphostin A1 Tyrphostin 1; AG9	Interleukin Related	Inflammation/Immunology
Tyrphostin A1(AG9) inhibits CD40L-stimulated IL-12 production in macrophage cultures and antigen-induced generation of Th1 cells.

Cat. No.	Product Name	Type

HY-D1124

Mordant brown 1	Dyes
Mordant brown 1, a naphthalenesulphonic acid derivative, is an azo dye. Mordant brown 1 is also an effective and specific inhibitor of CD40-CD154 costimulatory protein-protein interaction.

Cat. No.	Product Name	Target	Research Area

HY-P99257

Bleselumab ASKP 1240; Anti-Human Cd40 Recombinant Antibody	Inhibitory Antibodies	Inflammation/Immunology
Bleselumab (ASKP 1240) is a human anti-CD40 monoclonal antibody (mAb). Bleselumab binds to human CD40 with high affinity (K_d: 0.24 nM). Bleselumab inhibits immune responses by blocking the interaction of CD40 with its ligand CD40L. Bleselumab prevents organ transplant rejection.

Cat. No.	Product Name

HY-131968

BMS-986202
BMS-986202 is a potent, selective and orally active Tyk2 inhibitor that binds to Tyk2 JH2 with an IC₅₀ value of 0.19 nM and a K_i of 0.02 nM. BMS-986202 is remarkably selective over other kinases including Jak family members. BMS-986202 is also a weak inhibitor of CYP2C19 with an IC₅₀ value of 14 μM. BMS-986202 can be used for IL-23-driven acanthosis, anti-CD40-induced colitis, and spontaneous lupus research. BMS-986202 is a de novo deuterium.

BMS-986202

BMS-986202 is a potent, selective and orally active Tyk2 inhibitor that binds to Tyk2 JH2 with an IC₅₀ value of 0.19 nM and a K_i of 0.02 nM. BMS-986202 is remarkably selective over other kinases including Jak family members. BMS-986202 is also a weak inhibitor of CYP2C19 with an IC₅₀ value of 14 μM. BMS-986202 can be used for IL-23-driven acanthosis, anti-CD40-induced colitis, and spontaneous lupus research. BMS-986202 is a de novo deuterium.

Name
Email *

	Sorry, but the email address you supplied was invalid.